MIR3909

Across TCGA pan-cancer cohorts, MIR3909 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of MIR3909’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR3909 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR3909 is over-expressed in tumor, although a few such as THCA and LUSC show the opposite, repressed pattern.

KIRC, STAD, and UCEC are the cancer types where MIR3909 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3909 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	+0.150	.005	6	view →
STAD	Male	II,III,IV	+0.412	.003	2	view →
UCEC	All	All	+0.186	.026	2	view →
LIHC	Female	All	+0.185	.004	2	view →
THCA	All	III,IV	−0.163	.014	2	view →
BLCA	Male	IV	+0.585	.039	1	view →
LUSC	Female	All	−0.439	.006	1	view →
CHOL	All	All	+0.301	.027	1	view →
HNSC	Female	III,IV	−0.300	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

MIR3909–KIRC

Open the KIRC breakdown →